Effects of Ischemic Preconditioning on Muscle Damage Induced by Excentric Exercise

Paulista University

Status: Completed

Conditions: Healthy

Treatments: Device: Ischemic Preconditioning

Study type: Interventional

Funder types: Other

Identifiers

NCT04420819

FCT/UNESP

Details and patient eligibility

About

Introduction: eccentric exercise (EE) has been widely used in rehabilitation and in improving physical fitness due to its mechanical advantage and less metabolic demand, however, EE can induce muscle damage providing structural changes and reduced muscle function, therefore, it is necessary to look for alternatives to reduce this damage caused by stress. Thus, ischemic preconditioning (PCI) can be seen as an aid in reducing the damage caused by EE, as it can attenuate the ischemia-reperfusion injury, and can be used to accelerate the post-exercise recovery process. Objectives: to compare the effects of PCI, using different occlusion pressures, on acute and late responses to perceptual outcomes and muscle injury markers, in addition to checking whether the technique causes deleterious effects on performance in post-exercise recovery. Methods: a randomized placebo controlled clinical trial will be conducted with 80 healthy men aged 18 to 35 years who will be randomly divided into four groups: PCI using total occlusion pressure (POT), PCI with 40% more than POT, placebo (10 mmHg) and control. The PCI protocol will consist of four cycles of ischemia and reperfusion of five minutes each. All groups will perform an EE protocol, initial assessments, immediately after the end of the EE, 24, 48, 72 and 96 hours after exercise, with the maximum isometric voluntary contraction (CVIM) assessed by the isokinetic dynamometer, vectors of cell integrity by by means of electrical bioimpedance (BIA), creatine kinase (CK), blood lactate, pain on the visual analog scale (VAS), pain threshold by the pressure algometer, and tone, muscle rigidity and elasticity by myotonometry. The descriptive statistical method and analysis of variance will be used for the repeated measures model. The level of significance will be p <0.05.

Enrollment: 80 patients

Sex: Male

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• not having any health condition that contraindicates or prevents EE;
• not having diagnosed diabetes and high blood pressure;
• not having inflammatory, psychiatric, cardiovascular and / or respiratory rheumatic disease;
• not being an alcoholic, using drugs and / or a smoker;
• without a history of knee surgery (for example, meniscal repair and ligament reconstruction) or recent musculoskeletal injury to the lower limbs that may impair performance during tests or interventions (for example, muscle injury, tendinopathy, patellofemoral pain in the lower limbs and / or back pain in the last six months);
• without involvement in any type of training program during the study period;
• not being engaged in the lower limb strength training program during the three months prior to participating in the study;
• not using ergogenic supplements to improve physical performance and / or muscle mass and / or vasoactive drugs;
• not having one or more risk factors predisposing to thromboembolism.

Exclusion criteria

• present a health problem that does not allow continuity,
• use medication, electrotherapy or other therapeutic means that may interfere with any result;
• perform unusual or strenuous physical activities during the evaluation period;
• want to leave the study.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

80 participants in 4 patient groups, including a placebo group

IPC-LOP

Experimental group

Description:

this group will carry out the baseline assessments, perform the ischemic preconditioning using exactly the limb occlusion pressure , then perform post-IPC assessments and start the excentric exercise, and the post-exercise assessments will take place immediately after the end of the EE and will be repeated in 24h, 48h, 72h and 96h.

Treatment:

Device: Ischemic Preconditioning

IPC-40%

Experimental group

Description:

this group will carry out baseline assessments, perform IPC using 40% more occlusion than LOP, then perform assessments after IPC protocol and start EE, and post exercise assessments will take place immediately after the end of EE and will be repeated in 24h, 48h, 72h and 96h.

Treatment:

Device: Ischemic Preconditioning

IPC-10mmHg:

Placebo Comparator group

Description:

this group will perform baseline assessments, perform occlusion-perfusion intervention with 10 mmHg restriction characterizing the placebo, then perform post-IPC assessments and initiate EE, and post-exercise assessments will take place immediately after completion of EE and if will repeat in 24h, 48h, 72h and 96h.

Treatment:

Device: Ischemic Preconditioning

CONTR

No Intervention group

Description:

this group will carry out the baseline assessments, immediately after starting the EE, and the post-exercise assessments will happen immediately after the end of the EE and will be repeated in 24h, 48h, 72h and 96h.